| human | Q5 |
| P496 | ORCID iD | 0000-0002-3208-9308 |
| P735 | given name | Alicia | Q13232504 |
| Alicia | Q13232504 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | female | Q6581072 |
| Q55475676 | 1056Factors Associated with Pre-season Seroprotection to B Lineage Influenza Viruses in Children. |
| Q55030923 | 1057Factors Associated with Influenza A (H1N1)pdm09 (pH1N1) Vaccine Failure among Children Aged 5-17 Years. |
| Q50351153 | 1714Influenza antiviral agent use among adults hospitalized with community-acquired pneumonia. |
| Q38410159 | 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type |
| Q94116247 | 2062. Improving Antibiotic Prescribing in the Ambulatory Care Setting—Stewardship through Influenza Vaccination, US Flu VE Network 2013–2014 Through 2017–2018 |
| Q59334829 | 2553. Individual Patient-Level Data Meta-Analysis of Live Attenuated and Inactivated Influenza Vaccine Effectiveness Among US Children, 2013–2014 Through 2015–2016 |
| Q94136705 | 2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018 |
| Q94132008 | 2738. Influenza Vaccination During Pregnancy Among Mothers of Infants with Acute Respiratory Illness, United States, 2016–2018 |
| Q55002098 | 535Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network. |
| Q55504360 | 650Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network. |
| Q59333432 | 721. Clinical Respiratory Syndromes and Association with Influenza Clinical Diagnostic Testing and Antiviral Treatment among Children Hospitalized with Acute Respiratory Illness, 2015–2016 |
| Q59327368 | 745. Surveillance for Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus Infections During 2016–2017 and 2017–2018, United States |
| Q50355289 | 789Outpatient Antiviral Prescribing Practices among Providers in the U.S. Influenza Incidence Surveillance Project, 2009–2014. |
| Q94118817 | 898. Influenza Vaccination Reduces Risk of Severe Outcomes among Adults Hospitalized with Influenza A(H1N1)pdm09, FluSurv-NET, 2013–2018 |
| Q94117097 | 899. Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children Hospitalized with Respiratory Illness in the United States, 2016–2017 and 2017–2018 Seasons |
| Q59327672 | 988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018 |
| Q37581851 | A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants |
| Q54180498 | A Randomized Study Evaluating the Effectiveness of Oseltamivir Initiated at the Time of Hospital Admission in Adults Hospitalized With Influenza-Associated Lower Respiratory Tract Infections. |
| Q42282531 | A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility--North Carolina and South Carolina, 2010-2011. |
| Q33894593 | A comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006. |
| Q30398290 | A comparison of the epidemiology and clinical presentation of seasonal influenza A and 2009 pandemic influenza A (H1N1) in Guatemala |
| Q43173023 | A method for estimating vaccine-preventable pediatric influenza pneumonia hospitalizations in developing countries: Thailand as a case study |
| Q97907136 | A prospective cohort study in non-hospitalized household contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time |
| Q39566483 | A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama |
| Q44976386 | A summary of national reports of foodborne outbreaks of Salmonella Heidelberg infections in the United States: clues for disease prevention |
| Q30226709 | A survey of emergency department 2009 pandemic influenza A (H1N1) surge preparedness--Atlanta, Georgia, July-October 2009. |
| Q87056580 | Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 — United States, January–February 2020 |
| Q28390552 | Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001 |
| Q43121280 | Adults with diabetes hospitalized with pandemic influenza A(H1N1)pdm09--U.S. 2009. |
| Q51693231 | Advancing treatment options for influenza: challenges with the human influenza challenge. |
| Q33880235 | An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality |
| Q30413041 | Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States |
| Q45152293 | Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). |
| Q30410899 | Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives |
| Q30373020 | Antiviral treatment among older adults hospitalized with influenza, 2006-2012 |
| Q30411876 | Antiviral treatment of influenza in children |
| Q43185903 | Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States |
| Q35168895 | Application of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) viruses |
| Q61814222 | Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons |
| Q36396691 | Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination |
| Q30426626 | Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009 |
| Q45324690 | Avian Influenza A(H7N2) Virus in Human Exposed to Sick Cats, New York, USA, 2016. |
| Q33628728 | Avian influenza virus A (H5N1), detected through routine surveillance, in child, Bangladesh |
| Q91917812 | Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps |
| Q64124747 | Birth Cohort Effects in Influenza Surveillance Data: Evidence that First Influenza Infection Affects Later Influenza-Associated Illness |
| Q41987556 | Burden of Pneumonia-Associated Hospitalizations - United States, 2001-2014. |
| Q101061525 | COVID-19-Associated Hospitalizations Among Health Care Personnel - COVID-NET, 13 States, March 1-May 31, 2020 |
| Q39530697 | Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011. |
| Q99707388 | Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020 |
| Q30399317 | Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States |
| Q42199847 | Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. |
| Q64128418 | Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa |
| Q64134362 | Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa |
| Q37087113 | Clinical and virologic outcomes in patients with oseltamivir-resistant seasonal influenza A (H1N1) infections: results from a clinical trial |
| Q30400049 | Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009 |
| Q41932743 | Commentary: A Historical Review of Centers for Disease Control and Prevention Antiviral Treatment and Postexposure Chemoprophylaxis Guidance for Human Infections With Novel Influenza A Viruses Associated With Severe Human Disease |
| Q40280177 | Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014. |
| Q91901896 | Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial |
| Q42218621 | Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection |
| Q64134455 | Comparing influenza vaccine types: the path towards improved influenza vaccine strategies |
| Q51696425 | Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. |
| Q92883654 | Comparison of Respiratory Specimen Collection Methods for Detection of Influenza Virus Infection by Reverse Transcription-PCR: a Literature Review |
| Q35408014 | Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel |
| Q30397287 | Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro |
| Q43230344 | Coronavirus antibodies in bat biologists |
| Q64131293 | Current challenges in the risk assessment of neuraminidase inhibitor-resistant influenza viruses |
| Q64124882 | Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study |
| Q30373099 | Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. |
| Q30408429 | Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. |
| Q58610910 | Detection of Avian Influenza A(H7N2) Virus Infection Among Animal Shelter Workers Using a Novel Serological Approach-New York City, 2016-2017 |
| Q34124926 | Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa |
| Q45324778 | Do animal exhibitors support and follow recommendations to prevent transmission of variant influenza at agricultural fairs? A survey of animal exhibitor households after a variant influenza virus outbreak in Michigan |
| Q34292717 | Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria |
| Q34910490 | Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. |
| Q37523349 | Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010-2011. |
| Q92688869 | Early Season Pediatric Influenza B/Victoria Virus Infections Associated with a Recently Emerged Virus Subclade - Louisiana, 2019 |
| Q30411948 | Early detection of pandemic (H1N1) 2009, Bangladesh |
| Q41543622 | Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. |
| Q89477725 | Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017 |
| Q42215844 | Effectiveness of neuraminidase inhibitors for severe influenza |
| Q30352932 | Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US influenza surv |
| Q64130978 | Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season |
| Q92439597 | Effects of Influenza Vaccination in the United States during the 2018-2019 Influenza Season |
| Q37568436 | Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. |
| Q40264783 | Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial |
| Q30829284 | Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial |
| Q40152886 | Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial |
| Q47100142 | Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh |
| Q39508037 | Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir |
| Q95602390 | Enhanced Contact Investigations for Nine Early Travel-Related Cases of SARS-CoV-2 in the United States |
| Q40670577 | Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. |
| Q30399992 | Epidemiology of 2009 pandemic influenza A (H1N1) in the United States |
| Q41694953 | Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season |
| Q47159199 | Estimating Risk to Humans Exposed to Highly Pathogenic Avian Influenza Outbreaks in the United States, 2014–2017. |
| Q64073998 | Estimating Risk to Responders Exposed to Avian Influenza A H5 and H7 Viruses in Poultry, United States, 2014-2017 |
| Q30204152 | Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic |
| Q30387564 | Estimating the disease burden of pandemic (H1N1) 2009 virus infection in Hunter New England, Northern New South Wales, Australia, 2009 |
| Q41483857 | Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries |
| Q56969102 | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017 |
| Q42204936 | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013. |
| Q41344703 | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014. |
| Q37710503 | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015. |
| Q38627487 | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016. |
| Q98459083 | Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020 |
| Q91986443 | Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020 |
| Q57385001 | Hospitalization Trends for Pneumonia Among Older Persons—Reply |
| Q30224567 | Hospitalization due to human parainfluenza virus-associated lower respiratory tract illness in rural Thailand |
| Q58580913 | Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16 |
| Q40188831 | Hospitalizations Attributable to Respiratory Infections among Children with Neurologic Disorders |
| Q42202303 | Hospitalizations for severe lower respiratory tract infections |
| Q38403505 | Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010-2012. |
| Q28260987 | Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 |
| Q33588584 | Household air quality risk factors associated with childhood pneumonia in urban Dhaka, Bangladesh |
| Q30387397 | Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April-May 2009. |
| Q43169598 | Household-level risk factors for influenza among young children in Dhaka, Bangladesh: a case-control study |
| Q40078626 | Household-level risk factors for secondary influenza-like illness in a rural area of Bangladesh |
| Q43176420 | Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand |
| Q43176007 | Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays |
| Q33867571 | Human rhinovirus infections in rural Thailand: epidemiological evidence for rhinovirus as both pathogen and bystander |
| Q91181999 | Identification of novel influenza A virus exposures by an improved high-throughput multiplex MAGPIX platform and serum adsorption |
| Q64135434 | Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh |
| Q35661251 | Impact of Intensive Handwashing Promotion on Secondary Household Influenza-Like Illness in Rural Bangladesh: Findings from a Randomized Controlled Trial |
| Q41499087 | Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial |
| Q51774621 | Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. |
| Q40129065 | Incidence and characteristics of early childhood wheezing, Dhaka, Bangladesh, 2004-2010. |
| Q36341657 | Incidence and etiology of acute lower respiratory tract infections in hospitalized children younger than 5 years in rural Thailand |
| Q35678827 | Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010. |
| Q30428191 | Incidence of respiratory virus-associated pneumonia in urban poor young children of Dhaka, Bangladesh, 2009-2011. |
| Q30227419 | Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008. |
| Q38917604 | Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic - China, October 2016-February 2017. |
| Q30396792 | Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015 |
| Q40131070 | Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh |
| Q45118572 | Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States |
| Q47549841 | Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States |
| Q39696596 | Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine |
| Q60302132 | Influenza Activity - United States, September 30-December 1, 2018 |
| Q47720310 | Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016. |
| Q35847269 | Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11 |
| Q46133830 | Influenza Clinical Diagnostic Testing and Antiviral Treatment among Children Hospitalized with Acute Respiratory Illness During the 2015–16 Influenza Season. |
| Q50101205 | Influenza Vaccination Coverage in Children with Neurologic Disorders and Their Siblings, July 2006-June 2014. |
| Q90609773 | Influenza Vaccine Effectiveness |
| Q30383312 | Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. |
| Q38756456 | Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014. |
| Q58110187 | Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017 |
| Q37568360 | Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses |
| Q47118773 | Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season. |
| Q40089214 | Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season |
| Q59352861 | Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season |
| Q42925959 | Influenza antiviral prescribing practices during the 2007–08 and 2008–09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses |
| Q33521203 | Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008 |
| Q38922422 | Influenza is a major contributor to childhood pneumonia in a tropical developing country |
| Q33776771 | Influenza vaccination and treatment in children with neurologic disorders |
| Q38774410 | Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza |
| Q59351229 | Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016 |
| Q35715694 | Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility |
| Q35531934 | Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type |
| Q50026189 | Influenza-Associated Pediatric Deaths in the United States, 2010-2016. |
| Q49166123 | Influenza-Associated Pediatric Deaths in the United States, 2010–2015. |
| Q57384996 | Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection |
| Q37087067 | Influenza-associated mortality among children - United States: 2007-2008 |
| Q35884755 | Influenza-associated mortality in 2009 in four sentinel sites in Bangladesh |
| Q42259236 | Influenza-associated pediatric deaths in the United States, 2004-2012. |
| Q36174771 | Influenza-like illness, the time to seek healthcare, and influenza antiviral receipt during the 2010-2011 influenza season-United States |
| Q26154903 | Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001 |
| Q87461459 | Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020 |
| Q30417639 | Intensive care unit patients with 2009 pandemic influenza A (H1N1pdm09) virus infection - United States, 2009. |
| Q95605744 | Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) |
| Q38957414 | Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. |
| Q49981002 | Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. |
| Q64243916 | Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019 |
| Q89802120 | Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020 |
| Q30359268 | Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. |
| Q64138058 | Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018 |
| Q38403538 | Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15. |
| Q96017477 | Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, United States |
| Q43451826 | Legionnaires' disease outbreak in an automobile engine manufacturing plant |
| Q50229611 | Letter in response to commentary by Small and Cronin |
| Q42381530 | Letter to the editor: Regarding the editorial by Penttinen and Friede |
| Q64133129 | Live Attenuated and Inactivated Influenza Vaccine Effectiveness |
| Q30224881 | Low usage of government healthcare facilities for acute respiratory infections in guatemala: implications for influenza surveillance |
| Q30425367 | Lower respiratory tract hemorrhage associated with 2009 pandemic influenza A (H1N1) virus infection |
| Q47886776 | Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses |
| Q44315959 | Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults |
| Q33698075 | Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART |
| Q30387004 | Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. |
| Q35847411 | Multidrug-resistant tuberculosis detection, Latvia |
| Q30372421 | Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses |
| Q30412663 | Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods |
| Q92794658 | Note to readers |
| Q33629039 | Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia |
| Q34843761 | Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14. |
| Q30412554 | Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. |
| Q40482025 | Outbreak of Influenza A(H3N2) Variant Virus Infections Among Persons Attending Agricultural Fairs Housing Infected Swine - Michigan and Ohio, July-August 2016. |
| Q41919189 | Outbreak of Influenza A(H7N2) Among Cats in an Animal Shelter with Cat-to-Human Transmission - New York City, 2016. |
| Q34603566 | Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008. |
| Q35672280 | Outbreaks of short-incubation ocular and respiratory illness following exposure to indoor swimming pools |
| Q64132510 | Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons |
| Q30388312 | Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States |
| Q35073785 | Pattern of antibiotic use in a trachoma-endemic region of Nepal: implications for mass azithromycin distribution |
| Q64128715 | Peramivir: another tool for influenza treatment? |
| Q46408976 | Persistence of fluoroquinolone-resistant, multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: efforts to reduce intrafacility transmission |
| Q87461581 | Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020 |
| Q40116957 | Pilot Intervention Study of Household Ventilation and Fine Particulate Matter Concentrations in a Low-Income Urban Area, Dhaka, Bangladesh |
| Q57928433 | Population-Based Incidence of Childhood Pneumonia Associated with Viral Infections in Bangladesh |
| Q35108485 | Population-based incidence of severe acute respiratory virus infections among children aged <5 years in rural Bangladesh, June-October 2010 |
| Q30388373 | Population-based surveillance for 2009 pandemic influenza A (H1N1) virus in Guatemala, 2009 |
| Q30399886 | Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns |
| Q28741061 | Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009 |
| Q30423135 | Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic |
| Q40070473 | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season |
| Q92813244 | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season |
| Q58709341 | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season |
| Q91311604 | Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children - A systematic review and a meta-analysis |
| Q40152643 | Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States |
| Q92174282 | Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden - United States |
| Q53449602 | Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. |
| Q54146440 | RE: "INVITED COMMENTARY: BEWARE THE TEST-NEGATIVE DESIGN". |
| Q47106164 | Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults |
| Q38431288 | Rates of hospital-acquired respiratory illness in Bangladeshi tertiary care hospitals: results from a low-cost pilot surveillance strategy |
| Q35073344 | Real-time PCR assays for detection of bocavirus in human specimens |
| Q42881052 | Recovery of a Multidrug‐Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with Oseltamivir |
| Q30416134 | Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic |
| Q40668092 | Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees |
| Q93168693 | Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination |
| Q98497953 | Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19 |
| Q64124043 | Reply to Gonzales-Luna and Carlson |
| Q38388812 | Respiratory Viral Testing and Influenza Antiviral Prescriptions During Hospitalization for Acute Respiratory Illnesses |
| Q41931250 | Respiratory syncytial virus hospitalization in middle-aged and older adults |
| Q35557380 | Results of a pilot study using self-collected mid-turbinate nasal swabs for detection of influenza virus infection among pregnant women |
| Q99567843 | Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System |
| Q97561776 | Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) |
| Q30423248 | Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010. |
| Q36518793 | Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine |
| Q40287101 | Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. |
| Q30406004 | Serologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009. |
| Q45361935 | Serology as an adjunct to polymerase chain reaction assays for surveillance of acute respiratory virus infections |
| Q97639262 | Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 |
| Q30431244 | Severe acute respiratory infections caused by 2009 pandemic influenza A (H1N1) among American Indians--southwestern United States, May 1-July 21, 2009. |
| Q91006502 | Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season |
| Q50041580 | Statin use and risks of influenza-related outcomes among older adults receiving standard-dose or high-dose influenza vaccines through Medicare during 2010-2015. |
| Q30381731 | Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated |
| Q38299002 | Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-2013 |
| Q64125150 | Text-Based Illness Monitoring for Detection of Novel Influenza A Virus Infections During an Influenza A (H3N2)v Virus Outbreak in Michigan, 2016: Surveillance and Survey |
| Q30208864 | The Economics of Strategies to Reduce Respiratory Syncytial Virus Hospitalizations in Alaska |
| Q41919202 | The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine |
| Q30420994 | The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall of 2009. |
| Q33769879 | The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand |
| Q42234781 | The burden of influenza hospitalizations in infants from 2003 to 2012, United States |
| Q37260000 | The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings |
| Q30413353 | The first cases of 2009 pandemic influenza A (H1N1) virus infection in the United States: a serologic investigation demonstrating early transmission |
| Q46516644 | The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults |
| Q35593627 | Topical ocular antibiotics induce bacterial resistance at extraocular sites |
| Q35895991 | Trachoma decline and widespread use of antimicrobial drugs |
| Q44185151 | Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. |
| Q45357822 | Understanding influenza virus resistance to antiviral agents; early warning signs for wider community circulation |
| Q54981943 | Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season. |
| Q40053892 | Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017. |
| Q40223224 | Update: Influenza Activity - United States |
| Q90628742 | Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine |
| Q57784339 | Update: Influenza Activity - United States and Worldwide, May 20-October 13, 2018 |
| Q41923696 | Update: Influenza Activity - United States and Worldwide, May 21-September 23, 2017. |
| Q40530977 | Update: Influenza Activity - United States and Worldwide, May 22-September 10, 2016. |
| Q49980944 | Update: Influenza Activity - United States, October 1, 2017-February 3, 2018. |
| Q47350852 | Update: Influenza Activity - United States, October 1-November 25, 2017. |
| Q38957422 | Update: Influenza Activity - United States, October 2, 2016-February 4, 2017. |
| Q39053223 | Update: Influenza Activity - United States, October 2-December 17, 2016. |
| Q64130147 | Update: Influenza Activity - United States, September 30, 2018-February 2, 2019 |
| Q38702418 | Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine |
| Q55339400 | Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine. |
| Q64954871 | Update: Influenza Activity in the United States During the 2018-19 Season and Composition of the 2019-20 Influenza Vaccine. |
| Q40518701 | Update: Influenza Activity--United States and Worldwide, May 24-September 5, 2015. |
| Q39986655 | Update: Influenza Activity--United States, October 4, 2015-February 6, 2016. |
| Q34354261 | Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season |
| Q35974465 | Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season |
| Q30404732 | Use of intravenous neuraminidase inhibitors during the 2009 pandemic: results from population-based surveillance |
| Q92437394 | Vaccination history as a confounder of studies of influenza vaccine effectiveness |
| Q89934198 | Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015-2016 |
| Q97886487 | Vaccine Effectiveness Against Influenza-Associated Lower Respiratory Tract Infections in Hospitalized Adults, Louisville, Kentucky, 2010-2013 |
| Q100454047 | Vaccine Effectiveness Against Pediatric Influenza Hospitalizations and Emergency Visits |
| Q30399982 | Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak--Pennsylvania, May-June 2009. |
| Q30399985 | Virus detection and duration of illness among patients with 2009 pandemic influenza A (H1N1) virus infection in Texas |
| Q93140165 | Waning of Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults |
| Q90750417 | Waning of measured influenza vaccine effectiveness over time: the potential contribution of leaky vaccine effect |
Search more.